In vitro induction of alkaline phosphatase levels predicts in vivo bone forming capacity of human bone marrow stromal cells

Stem Cell Research

Volumn 12, Issue 2, 2014, Pages 428-440

  Prins, Henk Jan ^a   Braat, A Koen ^a   Gawlitta, D ^a   Dhert, Wouter J A ^a   Egan, David A ^a   Tijssen Slump, Estel ^a   Yuan, Huipin ^c   Coffer, Paul J ^a,b   Rozemuller, Henk ^a   Martens, Anton C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c XPand Biotechnology BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA;

ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW; BONE MARROW BIOPSY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CHONDROGENESIS; COLONY FORMING UNIT F; CONTROLLED STUDY; DILUTION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; STROMA CELL; ANIMAL; CELL CULTURE; CHILD; CYTOLOGY; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; ENZYME INDUCTION; GENE EXPRESSION; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 84891425089     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.12.001     Document Type: Article

References (68)

1. Abdallah B.M., Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008, 15(2):109-116.
2. Agata H., Asahina I., Watanabe N., Ishii Y., Kubo N., Ohshima S., Kagami H. Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage. Tissue Eng. Part A 2010, 16(2):663-673.
3. Alves H., Mentink A., Le B., van Blitterswijk C.A., de Boer J. Effect of antioxidant supplementation on the total yield, oxidative stress levels, and multipotency of bone marrow-derived human mesenchymal stromal cells. Tissue Eng. Part A 2013, 19(7-8):928-937. [Research Support, Non-U.S. Gov't].
4. Aslan H., Zilberman Y., Kandel L., Liebergall M., Oskouian R.J., Gazit D., Gazit Z. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 2006, 24(7):1728-1737.
5. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25(6):1384-1392.
6. Battula V.L., Treml S., Abele H., Buhring H.J. Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 2008, 76(4):326-336.
7. Buhring H.J., Battula V.L., Treml S., Schewe B., Kanz L., Vogel W. Novel markers for the prospective isolation of human MSC. Ann. N. Y. Acad. Sci. 2007, 1106:262-271. [Research Support, Non-U.S. Gov't].
8. Chung M.T., Liu C., Hyun J.S., Lo D.D., Montoro D.T., Hasegawa M., Wan D.C. CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells. Tissue Eng. Part A 2013, 19(7-8):989-997.
9. Colter D.C., Class R., DiGirolamo C.M., Prockop D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(7):3213-3218.
10. Colter D.C., Sekiya I., Prockop D.J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(14):7841-7845.
11. Deschaseaux F., Gindraux F., Saadi R., Obert L., Chalmers D., Herve P. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br. J. Haematol. 2003, 122(3):506-517.
12. Di Maggio N., Piccinini E., Jaworski M., Trumpp A., Wendt D.J., Martin I. Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials 2011, 32(2):321-329.
13. Digirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol. 1999, 107(2):275-281.
14. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8(4):315-317.
15. Dominici M., Paolucci P., Conte P., Horwitz E.M. Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation 2009, 87(9 Suppl.):S36-S42.
16. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Piccolo S. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474(7350):179-183. [Research Support, Non-U.S. Gov't].
17. Engler A.J., Sen S., Sweeney H.L., Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 2006, 126(4):677-689.
18. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim. Biophys. Acta 1986, 883(2):173-177.
19. Friedenstein A.J., Deriglasova U.F., Kulagina N.N., Panasuk A.F., Rudakowa S.F., Luria E.A., Ruadkow I.A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol. 1974, 2(2):83-92.
20. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 1976, 4(5):267-274.
21. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6(2):230-247.
22. Gang E.J., Bosnakovski D., Figueiredo C.A., Visser J.W., Perlingeiro R.C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007, 109(4):1743-1751.
23. Gentry T., Foster S., Winstead L., Deibert E., Fiordalisi M., Balber A. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy 2007, 9(3):259-274.
24. Goldstein S.A., Patil P.V., Moalli M.R. Perspectives on tissue engineering of bone. Clin. Orthop. Relat. Res. 1999, (Suppl. 367):S419-S423.
25. Groen R.W., de Rooij M.F., Kocemba K.A., Reijmers R.M., de Haan-Kramer A., Overdijk M.B., Spaargaren M. N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation. Haematologica 2011, 96(11):1653-1661.
26. Groen R.W., Noort W.A., Raymakers R.A., Prins H.J., Aalders L., Hofhuis F.M., Martens A.C. Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma. Blood 2012, 120(3):e9-e16.
27. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997, 64(2):295-312.
28. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418(6893):41-49.
29. Kolf C.M., Cho E., Tuan R.S. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res. Ther. 2007, 9(1):204.
30. Kuznetsov S.A., Krebsbach P.H., Satomura K., Kerr J., Riminucci M., Benayahu D., Robey P.G. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 1997, 12(9):1335-1347.
31. Larsen K.H., Frederiksen C.M., Burns J.S., Abdallah B.M., Kassem M. Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J. Bone Miner. Res. 2010, 25(4):796-808.
32. Lee C.C., Christensen J.E., Yoder M.C., Tarantal A.F. Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp. Hematol. 2010, 38(1):46-54.
33. Leyva-Leyva M., Barrera L., Lopez-Camarillo C., Arriaga-Pizano L., Orozco-Hoyuela G., Carrillo-Casas E.M., Fuentes-Mera L. Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential. Stem Cells Dev. 2013, 22(8):1275-1287.
34. Liu P.G., Zhou D.B., Shen T. Identification of human bone marrow mesenchymal stem cells: preparation and utilization of two monoclonal antibodies against SH2, SH3. J. Exp. Hematol. Chin. Assoc. Pathophysiol. 2005, 13(4):656-659.
35. Majumdar M.K., Banks V., Peluso D.P., Morris E.A. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J. Cell. Physiol. 2000, 185(1):98-106.
36. Martinez C., Hofmann T.J., Marino R., Dominici M., Horwitz E.M. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 2007, 109(10):4245-4248.
37. Meijer G.J., de Bruijn J.D., Koole R., van Blitterswijk C.A. Cell-based bone tissue engineering. PLoS Med. 2007, 4(2):e9.
38. Mendes S.C., Tibbe J.M., Veenhof M., Bakker K., Both S., Platenburg P.P., van Blitterswijk C.A. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng. 2002, 8(6):911-920.
39. Mendes S.C., Tibbe J.M., Veenhof M., Both S., Oner F.C., van Blitterswijk C.A., de Bruijn J.D. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J. Mater. Sci. Mater. Med. 2004, 15(10):1123-1128.
40. Mentink A., Hulsman M., Groen N., Licht R., Dechering K.J., van der Stok J., de Boer J. Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1. Biomaterials 2013, 34(19):4592-4601.
41. Phinney D.G., Kopen G., Righter W., Webster S., Tremain N., Prockop D.J. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J. Cell. Biochem. 1999, 75(3):424-436. [Comparative Study In Vitro].
42. Phinney D.G., Prockop D.J. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007, 25(11):2896-2902.
43. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
44. Prins H.J., Rozemuller H., Vonk-Griffioen S., Verweij V.G., Dhert W.J., Slaper-Cortenbach I.C., Martens A.C. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng. Part A 2009, 15(12):3741-3751.
45. Quarto R., Mastrogiacomo M., Cancedda R., Kutepov S.M., Mukhachev V., Lavroukov A., Marcacci M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 2001, 344(5):385-386.
46. Quirici N., Soligo D., Bossolasco P., Servida F., Lumini C., Deliliers G.L. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp. Hematol. 2002, 30(7):783-791.
47. Rider D.A., Nalathamby T., Nurcombe V., Cool S.M. Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. J. Mol. Histol. 2007, 38(5):449-458.
48. Rozemuller H., Prins H.J., Naaijkens B., Staal J., Buhring H.J., Martens A.C. Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies. Stem Cells Dev. 2010, 19(12):1911-1921.
49. Russell K.C., Phinney D.G., Lacey M.R., Barrilleaux B.L., Meyertholen K.E., O'Connor K.C. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2010, 28(4):788-798.
50. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131(2):324-336.
51. Sarugaser R., Hanoun L., Keating A., Stanford W.L., Davies J.E. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One 2009, 4(8):e6498.
52. Satomura K., Derubeis A.R., Fedarko N.S., Ibaraki-O'Connor K., Kuznetsov S.A., Rowe D.W., Gehron Robey P. Receptor tyrosine kinase expression in human bone marrow stromal cells. J. Cell. Physiol. 1998, 177(3):426-438.
53. Schimming R., Schmelzeisen R. Tissue-engineered bone for maxillary sinus augmentation. J. Oral Maxillofac. Surg. 2004, 62(6):724-729.
54. Schultz O., Sittinger M., Haeupl T., Burmester G.R. Emerging strategies of bone and joint repair. Arthritis Res. 2000, 2(6):433-436.
55. Sekiya I., Larson B.L., Smith J.R., Pochampally R., Cui J.G., Prockop D.J. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 2002, 20(6):530-541.
56. Seshi B., Kumar S., Sellers D. Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages. Blood Cells Mol. Dis. 2000, 26(3):234-246.
57. Siddappa R., Licht R., van Blitterswijk C., de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J. Orthop. Res. 2007, 25(8):1029-1041.
58. Siddappa R., Martens A., Doorn J., Leusink A., Olivo C., Licht R., de Boer J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(20):7281-7286.
59. Simmons P.J., Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78(1):55-62.
60. Smith J.R., Pochampally R., Perry A., Hsu S.C., Prockop D.J. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells 2004, 22(5):823-831.
61. Sobiesiak M., Sivasubramaniyan K., Hermann C., Tan C., Orgel M., Treml S., Buhring H.J. The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev. 2010, 19(5):669-677.
62. Sorrentino A., Ferracin M., Castelli G., Biffoni M., Tomaselli G., Baiocchi M., Valtieri M. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp. Hematol. 2008, 36(8):1035-1046.
63. Stewart K., Monk P., Walsh S., Jefferiss C.M., Letchford J., Beresford J.N. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res. 2003, 313(3):281-290.
64. Tormin A., Brune J.C., Olsson E., Valcich J., Neuman U., Olofsson T., Scheding S. Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy 2009, 11(2):114-128.
65. Ueda M., Yamada Y., Kagami H., Hibi H. Injectable bone applied for ridge augmentation and dental implant placement: human progress study. Implant. Dent. 2008, 17(1):82-90.
66. Vogel W., Grunebach F., Messam C.A., Kanz L., Brugger W., Buhring H.J. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica 2003, 88(2):126-133.
67. Yuan H., Fernandes H., Habibovic P., de Boer J., Barradas A.M., de Ruiter A., de Bruijn J.D. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(31):13614-13619.
68. Yuan H., Van Den Doel M., Li S., Van Blitterswijk C.A., De Groot K., De Bruijn J.D. A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J. Mater. Sci. Mater. Med. 2002, 13(12):1271-1275.